Abstract
At the 2021 SOHO Annual Meeting, Maksim Mamonkin, PhD, of Baylor College of Medicine, reviewed progress in immunotherapy for T-cell lymphoma. Kelly Valla, PharmD, BCOP, of Winship Cancer Institute of Emory University, discusses key insights from this session for advanced practitioners.
